Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

664 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plitidepsin has a safe cardiac profile: a comprehensive analysis.
Soto-Matos A, Szyldergemajn S, Extremera S, Miguel-Lillo B, Alfaro V, Coronado C, Lardelli P, Roy E, Corrado CS, Kahatt C. Soto-Matos A, et al. Among authors: roy e. Mar Drugs. 2011;9(6):1007-1023. doi: 10.3390/md9061007. Epub 2011 Jun 9. Mar Drugs. 2011. PMID: 21747745 Free PMC article. Clinical Trial.
Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis.
Lebedinsky C, Gómez J, Park YC, Nieto A, Soto-Matos A, Parekh T, Alfaro V, Roy E, Lardelli P, Kahatt C. Lebedinsky C, et al. Among authors: roy e. Cancer Chemother Pharmacol. 2011 Nov;68(5):1223-31. doi: 10.1007/s00280-011-1614-z. Epub 2011 Mar 18. Cancer Chemother Pharmacol. 2011. PMID: 21416137 Clinical Trial.
A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin.
Grosso F, D'Incalci M, Cartoafa M, Nieto A, Fernández-Teruel C, Alfaro V, Lardelli P, Roy E, Gómez J, Kahatt C, Soto-Matos A, Judson I. Grosso F, et al. Among authors: roy e. Cancer Chemother Pharmacol. 2012 Jun;69(6):1557-65. doi: 10.1007/s00280-012-1864-4. Epub 2012 Apr 7. Cancer Chemother Pharmacol. 2012. PMID: 22484722 Free PMC article.
Acute myeloid leukemia unlikely related to trabectedin treatment.
Cartoafa M, Kahatt C, Soto-Matos A, Roy E, Lardelli P. Cartoafa M, et al. Among authors: roy e. Acta Haematol. 2011;126(4):238-9; author reply 240. doi: 10.1159/000330952. Epub 2011 Sep 24. Acta Haematol. 2011. PMID: 21952689 No abstract available.
A contest study to reduce attractiveness-based discrimination in social judgment.
Roy E, Jaeger B, Evans AM, Turetsky KM, O'Shea BA, Petersen MB, Singh B, Correll J, Zheng DY, Brown KW, Kirgios EL, Chang LW, Chang EH, Steele JR, Sebastien J, Sedgewick JR, Hackney A, Cook R, Yang X, Korkmaz A, Sim JJ, Khan N, Primbs MA, Bijlstra G, Faure R, Karremans JC, Santos LA, Voelkel JG, Marini M, Chen JM, Brown T, Yoon H, Morewedge CK, Scopelliti I, Hester N, Shen X, Ma M, Medvedev D, Ritchie EG, Lu C, Chang YP, Kumar A, Banerji R, Gretton JD, Schnabel L, Teachman BA, Kristal AS, Chua KW, Freeman JB, Fath S, Grigoryan L, Weißflog MI, Daryani Y, Pourhosein R, Johnson SK, Chan ET, Stevens SM, Anderson S, Beaty RE, Rubichi S, Cocco VM, Vezzali L, Lai CK, Axt JR. Roy E, et al. J Pers Soc Psychol. 2024 Nov 14. doi: 10.1037/pspa0000414. Online ahead of print. J Pers Soc Psychol. 2024. PMID: 39541527
List of Critical Drugs in Dermatology: Results of a Delphi Consensus in France.
Chaby G, Barbarot S, Corgibet F, Dauendorffer JN, Jouan N, Reverte M, Honoré S, Quereux G, Chosidow O; Centre of Evidence of the French Society of Dermatology. Chaby G, et al. Br J Dermatol. 2024 Nov 5:ljae427. doi: 10.1093/bjd/ljae427. Online ahead of print. Br J Dermatol. 2024. PMID: 39499664 No abstract available.
Heterojunction semiconductor nanocatalysts as cancer theranostics.
Sabu A, Kandel M, Sarma RR, Ramesan L, Roy E, Sharmila R, Chiu HC. Sabu A, et al. Among authors: roy e. APL Bioeng. 2024 Oct 4;8(4):041502. doi: 10.1063/5.0223718. eCollection 2024 Dec. APL Bioeng. 2024. PMID: 39381587 Free PMC article. Review.
664 results